EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 234 filers reported holding EXELIXIS INC in Q4 2016. The put-call ratio across all filers is 0.89 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84,215,646 | +25.6% | 3,854,263 | +9.8% | 0.03% | +30.4% |
| Q2 2023 | $67,076,921 | +115559.8% | 3,510,043 | +17.5% | 0.02% | +4.5% |
| Q1 2023 | $57,995 | +198.6% | 2,987,911 | +146.8% | 0.02% | +175.0% |
| Q4 2022 | $19,420 | -99.9% | 1,210,720 | +45.0% | 0.01% | +60.0% |
| Q3 2022 | $13,091,000 | -45.2% | 834,883 | -27.3% | 0.01% | -44.4% |
| Q2 2022 | $23,906,000 | +21.7% | 1,148,239 | +24.2% | 0.01% | +50.0% |
| Q1 2022 | $19,649,000 | +7.2% | 924,630 | -7.8% | 0.01% | +20.0% |
| Q4 2021 | $18,324,000 | -26.3% | 1,002,459 | -14.8% | 0.01% | -37.5% |
| Q3 2021 | $24,870,000 | -2.6% | 1,176,444 | -16.1% | 0.01% | 0.0% |
| Q2 2021 | $25,542,000 | -12.7% | 1,401,904 | +8.3% | 0.01% | -11.1% |
| Q1 2021 | $29,250,000 | +6.9% | 1,294,838 | -5.0% | 0.01% | 0.0% |
| Q4 2020 | $27,370,000 | -11.3% | 1,363,669 | +8.0% | 0.01% | -25.0% |
| Q3 2020 | $30,864,000 | -10.5% | 1,262,357 | -13.1% | 0.01% | -14.3% |
| Q2 2020 | $34,481,000 | +57.3% | 1,452,446 | +14.1% | 0.01% | +27.3% |
| Q1 2020 | $21,924,000 | -56.4% | 1,273,190 | -55.4% | 0.01% | -42.1% |
| Q4 2019 | $50,278,000 | -9.6% | 2,853,407 | -9.3% | 0.02% | -17.4% |
| Q3 2019 | $55,618,000 | +17.6% | 3,144,923 | +42.1% | 0.02% | +21.1% |
| Q2 2019 | $47,309,000 | +350.1% | 2,213,810 | +540.3% | 0.02% | -71.6% |
| Q4 2017 | $10,511,000 | +4207.8% | 345,758 | +2965.8% | 0.07% | +6600.0% |
| Q1 2017 | $244,000 | +15.1% | 11,278 | -20.8% | 0.00% | 0.0% |
| Q4 2016 | $212,000 | +10.4% | 14,233 | -5.4% | 0.00% | 0.0% |
| Q3 2016 | $192,000 | +62.7% | 15,047 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $118,000 | +93.4% | 15,047 | -1.5% | 0.00% | – |
| Q1 2016 | $61,000 | -32.2% | 15,272 | -4.7% | 0.00% | – |
| Q4 2015 | $90,000 | -3.2% | 16,028 | -3.8% | 0.00% | -100.0% |
| Q3 2015 | $93,000 | +69.1% | 16,662 | +14.9% | 0.00% | – |
| Q2 2015 | $55,000 | +41.0% | 14,499 | -4.0% | 0.00% | – |
| Q1 2015 | $39,000 | +77.3% | 15,100 | 0.0% | 0.00% | – |
| Q4 2014 | $22,000 | -12.0% | 15,100 | -6.5% | 0.00% | – |
| Q3 2014 | $25,000 | -54.5% | 16,146 | 0.0% | 0.00% | – |
| Q2 2014 | $55,000 | -3.5% | 16,146 | 0.0% | 0.00% | – |
| Q1 2014 | $57,000 | -39.4% | 16,146 | +5.4% | 0.00% | -100.0% |
| Q4 2013 | $94,000 | +13.3% | 15,318 | +7.8% | 0.00% | 0.0% |
| Q3 2013 | $83,000 | +38.3% | 14,209 | +7.3% | 0.00% | – |
| Q2 2013 | $60,000 | – | 13,243 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |